Clinical Cell and Vaccine Production Facility
directed by Bruce Levine, PhD
(215) 573-6788
a member since 6/30/2009

Contact Info

For information contact
Lori Landgrebe.

(215) 898-8794
University of Pennsylvania

USA

Services Provided

This facility provides research grade material and offers production support to both Academics and Companies.

Biologics Produced

  • working cell banks
  • Vaccines
  • Tumor Vaccines
  • mesenchymal stromal cells
  • Isolated and Expanded T-Cells
  • Gene-modified T-Cells
  • full GMP facility. Master cell banks
  • Antigen Specific T-cells

Vector Support

  • None

About this facility

The overall mission of the Clinical Cell and Vaccine Production Facility is to help translate insights into novel cellular therapies. Other important missions include:

  • To activate and/or gene transduce cells for allogeneic or autologous cell based cancer therapies.
  • To answer questions relative to the effectiveness of cell and gene therapy by analysis of patient samples.
  • To develop new and improved methods of ex vivo cell culture and gene transduction.
  • To maintain a knowledge of regulatory requirements and guidelines and provide expertise to Penn investigators and collaborators.
  • To increase the impact of potential novel cellular therapies by facilitating wide application of the techniques developed.